74

United States – Forecast for Off–Label Drugs Market Share


http://www.renub.com

Off–label use is very common in United States. United States Off–label Drugs demand has grown at a fast pace in the past decade and likely to grow in the forecasting period. It is likely that United States off–label market will cross the figure of 60 Billion by the year 2020. Central Nervous System (CNS) and Cancer off–label Drugs controls the largest market share of the total US off–label Drugs market. Anti–Infectives Off–Label Drugs Market and Anti–Ashmatics Off–Label Drugs together are expected to control close to 35% market share by 2020.

Read »
Created by renubresearch 21 weeks 5 days ago – Made popular 21 weeks 4 days ago
Category: Health   Tags:

User login

EzySpot is a news/social bookmarking site.
COT Market Watch by Frank Paul

Syndicate

Syndicate content